The story of adiponectin and its receptors AdipoR1 and R2: To follow

Journal of Hepatology

Volumn 47, Issue 5, 2007, Pages 736-738

  Capeau, Jacqueline ^a,b  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; DYSLIPIDEMIA; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HYPERTENSION; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 34848827915     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.06.002     Document Type: Article

References (14)

1. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
2. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116 (2006) 1784-1792
3. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003) 762-769
4. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13 (2007) 332-339
5. Combs T.P., Berg A.H., Obici S., Scherer P.E., and Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108 (2001) 1875-1881
6. Tomas E., Tsao T.S., Saha A.K., Murrey H.E., Zhang Cc.C., Itani S.I., et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99 (2002) 16309-16313
7. Hug C., Wang J., Ahmad N.S., Bogan J.S., Tsao T.S., and Lodish H.F. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 101 (2004) 10308-10313
8. Bjursell M., Ahnmark A., Bohlooly-Y M., William-Olsson L., Rhedin M., Peng X.R., et al. Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56 (2007) 583-593
9. Liu Y., Michael M.D., Kash S., Bensch W.R., Monia B.P., Murray S.F., et al. Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 148 (2007) 683-692
10. Tsochatzis E., Papatheodoridis G.V., and Archimandritis A.J. The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol 101 (2006) 2629-2640
11. Kaser S., Moschen A., Cayon A., Kaser A., Crespo J., Pons-Romero F., et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 54 (2005) 117-121
12. Vuppalanchi R., Marri S., Kolwankar D., Considine R.V., and Chalasani N. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study. J Clin Gastroenterol 39 (2005) 237-242
13. Liu C.J., Chen P.J., Jeng Y.M., Huang W.L., Yang W.S., Lai M.Y., et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J Hepatol 43 (2005) 235-242
14. Jonsson J.R., Moschen A.R., Hickman I.J., Richardson M.M., Kaser S., Clouston A.D., et al. Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol 43 (2005) 929-936